nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—UGT2B7—urinary bladder cancer	0.632	1	CbGaD
Chenodeoxycholic acid—UGT2B7—Epirubicin—urinary bladder cancer	0.0967	0.699	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Thiotepa—urinary bladder cancer	0.0285	0.206	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Etoposide—urinary bladder cancer	0.00774	0.056	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—urinary bladder cancer	0.00528	0.0382	CbGbCtD
Chenodeoxycholic acid—NR1H4—prostate gland—urinary bladder cancer	0.00451	0.125	CbGeAlD
Chenodeoxycholic acid—CYP27A1—prostate gland—urinary bladder cancer	0.00328	0.0909	CbGeAlD
Chenodeoxycholic acid—NR1H4—renal system—urinary bladder cancer	0.00307	0.0852	CbGeAlD
Chenodeoxycholic acid—UGT2B7—prostate gland—urinary bladder cancer	0.00291	0.0805	CbGeAlD
Chenodeoxycholic acid—CYP27A1—seminal vesicle—urinary bladder cancer	0.00278	0.0769	CbGeAlD
Chenodeoxycholic acid—NR1H4—female reproductive system—urinary bladder cancer	0.00246	0.0682	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00231	0.0365	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—renal system—urinary bladder cancer	0.00224	0.062	CbGeAlD
Chenodeoxycholic acid—CYP3A4—urine—urinary bladder cancer	0.00221	0.0611	CbGeAlD
Chenodeoxycholic acid—CYP27A1—urethra—urinary bladder cancer	0.0022	0.0609	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00201	0.0317	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—renal system—urinary bladder cancer	0.00198	0.0549	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00198	0.0313	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—female reproductive system—urinary bladder cancer	0.00179	0.0496	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00163	0.0257	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—vagina—urinary bladder cancer	0.00162	0.0449	CbGeAlD
Chenodeoxycholic acid—UGT2B7—female reproductive system—urinary bladder cancer	0.00159	0.0439	CbGeAlD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00147	0.0232	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—lymph node—urinary bladder cancer	0.00144	0.0399	CbGeAlD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00119	0.0188	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00117	0.0185	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00111	0.0175	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00109	0.0173	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00105	0.0166	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—NAT1—urinary bladder cancer	0.00105	0.0166	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—lymph node—urinary bladder cancer	0.00105	0.029	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00104	0.0164	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—NQO1—urinary bladder cancer	0.00103	0.0162	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00096	0.0152	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000947	0.015	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000864	0.0137	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000862	0.0136	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000853	0.0135	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTO2—urinary bladder cancer	0.000817	0.0129	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—NAT1—urinary bladder cancer	0.000817	0.0129	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000809	0.0128	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000787	0.0125	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTO2—urinary bladder cancer	0.000767	0.0121	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—NAT1—urinary bladder cancer	0.000767	0.0121	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.000711	0.0112	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000702	0.0111	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.000674	0.0107	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000632	0.00999	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.000611	0.00966	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—NAT2—urinary bladder cancer	0.000575	0.0091	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000567	0.00897	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000544	0.00861	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00054	0.00854	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—renal system—urinary bladder cancer	0.00054	0.015	CbGeAlD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTZ1—urinary bladder cancer	0.000504	0.00798	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000497	0.00787	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTO2—urinary bladder cancer	0.000478	0.00756	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—NAT1—urinary bladder cancer	0.000478	0.00756	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000472	0.00746	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00046	0.00727	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—NAT2—urinary bladder cancer	0.000448	0.00708	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000446	0.00705	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000438	0.00693	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—female reproductive system—urinary bladder cancer	0.000432	0.012	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000431	0.00682	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—NAT2—urinary bladder cancer	0.00042	0.00665	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP4B1—urinary bladder cancer	0.000394	0.00623	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000393	0.00622	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000388	0.00614	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000385	0.00609	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.000358	0.00567	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—HPGDS—urinary bladder cancer	0.000358	0.00566	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTT1—urinary bladder cancer	0.000347	0.00549	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—HPGDS—urinary bladder cancer	0.000336	0.00531	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000332	0.00525	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000331	0.00523	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTT1—urinary bladder cancer	0.000326	0.00515	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000309	0.00489	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000305	0.00482	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000297	0.00469	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000291	0.00459	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000284	0.00449	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00028	0.00443	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00028	0.00443	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—NAT2—urinary bladder cancer	0.000262	0.00414	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000258	0.00409	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000243	0.00384	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTP1—urinary bladder cancer	0.000241	0.00381	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000236	0.00373	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—urinary bladder cancer	0.000226	0.00357	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTM1—urinary bladder cancer	0.000221	0.0035	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Orphan transporters—CREBBP—urinary bladder cancer	0.000214	0.00338	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000213	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00021	0.00332	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—HPGDS—urinary bladder cancer	0.000209	0.00331	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000208	0.00329	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTM1—urinary bladder cancer	0.000208	0.00328	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000207	0.00328	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000204	0.00323	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTT1—urinary bladder cancer	0.000203	0.00321	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000202	0.0032	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.0002	0.00317	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.0002	0.00316	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—NQO1—urinary bladder cancer	0.000192	0.00304	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTZ1—urinary bladder cancer	0.000189	0.003	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000181	0.00286	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTO2—urinary bladder cancer	0.00018	0.00284	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NAT1—urinary bladder cancer	0.00018	0.00284	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000177	0.00279	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00017	0.00269	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00017	0.00268	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000165	0.00261	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—UGT2B7—urinary bladder cancer	0.000164	0.0026	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—urinary bladder cancer	0.000161	0.00254	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP4B1—urinary bladder cancer	0.000148	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTM1—urinary bladder cancer	0.000148	0.00233	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000143	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—urinary bladder cancer	0.000141	0.00223	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC19A1—urinary bladder cancer	0.00014	0.00221	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—EP300—urinary bladder cancer	0.000139	0.0022	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000139	0.0022	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTZ1—urinary bladder cancer	0.000138	0.00219	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000138	0.00218	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000136	0.00215	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PRSS3—urinary bladder cancer	0.000136	0.00215	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTO2—urinary bladder cancer	0.000131	0.00207	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NAT1—urinary bladder cancer	0.000131	0.00207	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTM1—urinary bladder cancer	0.000129	0.00205	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000129	0.00204	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000128	0.00202	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000123	0.00194	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—UGT2B7—urinary bladder cancer	0.00012	0.0019	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000116	0.00183	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000114	0.00181	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000112	0.00176	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00011	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00011	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000109	0.00173	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TYMP—urinary bladder cancer	0.000109	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000108	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP4B1—urinary bladder cancer	0.000108	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000104	0.00165	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC19A1—urinary bladder cancer	0.000102	0.00161	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.0001	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PRSS3—urinary bladder cancer	9.94e-05	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	9.9e-05	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NAT2—urinary bladder cancer	9.84e-05	0.00156	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NCOR1—urinary bladder cancer	9.48e-05	0.0015	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	9.39e-05	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	9.04e-05	0.00143	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	8.92e-05	0.00141	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTZ1—urinary bladder cancer	8.62e-05	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—RRM2—urinary bladder cancer	8.49e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTO2—urinary bladder cancer	8.18e-05	0.00129	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NAT1—urinary bladder cancer	8.18e-05	0.00129	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.97e-05	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMP—urinary bladder cancer	7.95e-05	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—HPGDS—urinary bladder cancer	7.86e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ENO2—urinary bladder cancer	7.86e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.82e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	7.79e-05	0.00123	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.63e-05	0.00121	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTT1—urinary bladder cancer	7.63e-05	0.00121	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.51e-05	0.00119	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—urinary bladder cancer	7.45e-05	0.00118	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NAT2—urinary bladder cancer	7.19e-05	0.00114	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Etoposide—urinary bladder cancer	6.9e-05	0.000529	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—urinary bladder cancer	6.89e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—urinary bladder cancer	6.89e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—urinary bladder cancer	6.87e-05	0.000527	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Etoposide—urinary bladder cancer	6.87e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Etoposide—urinary bladder cancer	6.87e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—urinary bladder cancer	6.87e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	6.87e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—urinary bladder cancer	6.85e-05	0.000525	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Methotrexate—urinary bladder cancer	6.85e-05	0.000525	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	6.84e-05	0.000525	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Methotrexate—urinary bladder cancer	6.83e-05	0.000523	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Cisplatin—urinary bladder cancer	6.8e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—urinary bladder cancer	6.8e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Methotrexate—urinary bladder cancer	6.8e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—urinary bladder cancer	6.8e-05	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SMC1A—urinary bladder cancer	6.78e-05	0.00107	CbGpPWpGaD
Chenodeoxycholic acid—Sweating—Doxorubicin—urinary bladder cancer	6.77e-05	0.000519	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—urinary bladder cancer	6.77e-05	0.000519	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—urinary bladder cancer	6.75e-05	0.000517	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—urinary bladder cancer	6.74e-05	0.000516	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—urinary bladder cancer	6.74e-05	0.000516	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP4B1—urinary bladder cancer	6.73e-05	0.00106	CbGpPWpGaD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—urinary bladder cancer	6.72e-05	0.000515	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	6.68e-05	0.000512	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—urinary bladder cancer	6.66e-05	0.000511	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Methotrexate—urinary bladder cancer	6.65e-05	0.000509	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—urinary bladder cancer	6.63e-05	0.000508	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Methotrexate—urinary bladder cancer	6.62e-05	0.000507	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Fluorouracil—urinary bladder cancer	6.62e-05	0.000507	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—urinary bladder cancer	6.61e-05	0.000506	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Methotrexate—urinary bladder cancer	6.6e-05	0.000506	CcSEcCtD
Chenodeoxycholic acid—Chills—Methotrexate—urinary bladder cancer	6.57e-05	0.000504	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CREBBP—urinary bladder cancer	6.53e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Cisplatin—urinary bladder cancer	6.49e-05	0.000497	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Methotrexate—urinary bladder cancer	6.47e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Gemcitabine—urinary bladder cancer	6.47e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Rash—Gemcitabine—urinary bladder cancer	6.42e-05	0.000492	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Gemcitabine—urinary bladder cancer	6.41e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Epirubicin—urinary bladder cancer	6.41e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Etoposide—urinary bladder cancer	6.4e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—urinary bladder cancer	6.39e-05	0.00049	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Methotrexate—urinary bladder cancer	6.38e-05	0.000489	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—urinary bladder cancer	6.37e-05	0.000489	CcSEcCtD
Chenodeoxycholic acid—Headache—Gemcitabine—urinary bladder cancer	6.37e-05	0.000488	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—urinary bladder cancer	6.36e-05	0.000488	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Fluorouracil—urinary bladder cancer	6.36e-05	0.000487	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—urinary bladder cancer	6.36e-05	0.000487	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC19A1—urinary bladder cancer	6.36e-05	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—urinary bladder cancer	6.34e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—NQO1—urinary bladder cancer	6.34e-05	0.001	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Fluorouracil—urinary bladder cancer	6.31e-05	0.000483	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Fluorouracil—urinary bladder cancer	6.3e-05	0.000483	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—urinary bladder cancer	6.3e-05	0.000482	CcSEcCtD
Chenodeoxycholic acid—Headache—Fluorouracil—urinary bladder cancer	6.27e-05	0.00048	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—urinary bladder cancer	6.26e-05	0.00048	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—urinary bladder cancer	6.25e-05	0.000479	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Etoposide—urinary bladder cancer	6.23e-05	0.000478	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—urinary bladder cancer	6.23e-05	0.000478	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—urinary bladder cancer	6.22e-05	0.000477	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—urinary bladder cancer	6.22e-05	0.000476	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RRM2—urinary bladder cancer	6.2e-05	0.000981	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PRSS3—urinary bladder cancer	6.2e-05	0.00098	CbGpPWpGaD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—urinary bladder cancer	6.19e-05	0.000474	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—urinary bladder cancer	6.18e-05	0.000473	CcSEcCtD
Chenodeoxycholic acid—Back pain—Methotrexate—urinary bladder cancer	6.17e-05	0.000473	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—urinary bladder cancer	6.15e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.15e-05	0.000973	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Etoposide—urinary bladder cancer	6.15e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—urinary bladder cancer	6.12e-05	0.000469	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—urinary bladder cancer	6.11e-05	0.000468	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Epirubicin—urinary bladder cancer	6.06e-05	0.000464	CcSEcCtD
Chenodeoxycholic acid—Nausea—Gemcitabine—urinary bladder cancer	6.04e-05	0.000463	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Cisplatin—urinary bladder cancer	6.03e-05	0.000462	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	6.02e-05	0.000952	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Cisplatin—urinary bladder cancer	5.98e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Cisplatin—urinary bladder cancer	5.97e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Epirubicin—urinary bladder cancer	5.97e-05	0.000457	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Etoposide—urinary bladder cancer	5.94e-05	0.000456	CcSEcCtD
Chenodeoxycholic acid—Nausea—Fluorouracil—urinary bladder cancer	5.94e-05	0.000455	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.93e-05	0.000938	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—urinary bladder cancer	5.93e-05	0.000454	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.92e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—urinary bladder cancer	5.91e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR2—urinary bladder cancer	5.91e-05	0.000935	CbGpPWpGaD
Chenodeoxycholic acid—Anaemia—Methotrexate—urinary bladder cancer	5.89e-05	0.000452	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—urinary bladder cancer	5.89e-05	0.000451	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Epirubicin—urinary bladder cancer	5.88e-05	0.000451	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—urinary bladder cancer	5.86e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—urinary bladder cancer	5.8e-05	0.000444	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—urinary bladder cancer	5.77e-05	0.000442	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—urinary bladder cancer	5.75e-05	0.000441	CcSEcCtD
Chenodeoxycholic acid—Malaise—Methotrexate—urinary bladder cancer	5.75e-05	0.000441	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—HPGDS—urinary bladder cancer	5.75e-05	0.000909	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ENO2—urinary bladder cancer	5.75e-05	0.000909	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Etoposide—urinary bladder cancer	5.75e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—urinary bladder cancer	5.74e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—urinary bladder cancer	5.73e-05	0.000439	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Methotrexate—urinary bladder cancer	5.73e-05	0.000439	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—urinary bladder cancer	5.72e-05	0.000438	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.71e-05	0.000904	CbGpPWpGaD
Chenodeoxycholic acid—Leukopenia—Methotrexate—urinary bladder cancer	5.71e-05	0.000437	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—urinary bladder cancer	5.69e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—urinary bladder cancer	5.67e-05	0.000434	CcSEcCtD
Chenodeoxycholic acid—Nausea—Cisplatin—urinary bladder cancer	5.63e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—urinary bladder cancer	5.6e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTT1—urinary bladder cancer	5.57e-05	0.000882	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Methotrexate—urinary bladder cancer	5.56e-05	0.000426	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	5.54e-05	0.000424	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Methotrexate—urinary bladder cancer	5.52e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Etoposide—urinary bladder cancer	5.52e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—urinary bladder cancer	5.52e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—urinary bladder cancer	5.52e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.49e-05	0.000868	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Etoposide—urinary bladder cancer	5.48e-05	0.00042	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Etoposide—urinary bladder cancer	5.47e-05	0.000419	CcSEcCtD
Chenodeoxycholic acid—Headache—Etoposide—urinary bladder cancer	5.44e-05	0.000417	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Doxorubicin—urinary bladder cancer	5.44e-05	0.000417	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Methotrexate—urinary bladder cancer	5.43e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Methotrexate—urinary bladder cancer	5.43e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Methotrexate—urinary bladder cancer	5.43e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—Tension—Doxorubicin—urinary bladder cancer	5.42e-05	0.000415	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	5.39e-05	0.000413	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—urinary bladder cancer	5.38e-05	0.000412	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Methotrexate—urinary bladder cancer	5.36e-05	0.000411	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.36e-05	0.000848	CbGpPWpGaD
Chenodeoxycholic acid—Nervousness—Doxorubicin—urinary bladder cancer	5.36e-05	0.000411	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—urinary bladder cancer	5.36e-05	0.000411	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—urinary bladder cancer	5.35e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—urinary bladder cancer	5.34e-05	0.000409	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—urinary bladder cancer	5.34e-05	0.000409	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—urinary bladder cancer	5.31e-05	0.000407	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—urinary bladder cancer	5.29e-05	0.000836	CbGpPWpGaD
Chenodeoxycholic acid—Palpitations—Epirubicin—urinary bladder cancer	5.27e-05	0.000404	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Methotrexate—urinary bladder cancer	5.25e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—urinary bladder cancer	5.24e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.22e-05	0.000825	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Epirubicin—urinary bladder cancer	5.21e-05	0.000399	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Epirubicin—urinary bladder cancer	5.17e-05	0.000396	CcSEcCtD
Chenodeoxycholic acid—Infection—Methotrexate—urinary bladder cancer	5.17e-05	0.000396	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etoposide—urinary bladder cancer	5.16e-05	0.000395	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—urinary bladder cancer	5.15e-05	0.000395	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	5.12e-05	0.000393	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.11e-05	0.000809	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Methotrexate—urinary bladder cancer	5.1e-05	0.000391	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—urinary bladder cancer	5.1e-05	0.000391	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	5.1e-05	0.00039	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—urinary bladder cancer	5.08e-05	0.000389	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—urinary bladder cancer	5.08e-05	0.000389	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—urinary bladder cancer	5.08e-05	0.000389	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Methotrexate—urinary bladder cancer	5.05e-05	0.000387	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	5.05e-05	0.000387	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Methotrexate—urinary bladder cancer	5.03e-05	0.000386	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—urinary bladder cancer	5.02e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Malaise—Doxorubicin—urinary bladder cancer	4.98e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—urinary bladder cancer	4.97e-05	0.000381	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—urinary bladder cancer	4.96e-05	0.00038	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Methotrexate—urinary bladder cancer	4.96e-05	0.00038	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMP—urinary bladder cancer	4.95e-05	0.000783	CbGpPWpGaD
Chenodeoxycholic acid—Syncope—Doxorubicin—urinary bladder cancer	4.95e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—urinary bladder cancer	4.94e-05	0.000379	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—TYMS—urinary bladder cancer	4.91e-05	0.000777	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Epirubicin—urinary bladder cancer	4.91e-05	0.000376	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—urinary bladder cancer	4.88e-05	0.000374	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—urinary bladder cancer	4.87e-05	0.000373	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Methotrexate—urinary bladder cancer	4.86e-05	0.000373	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—NCOR1—urinary bladder cancer	4.86e-05	0.000768	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTM1—urinary bladder cancer	4.86e-05	0.000768	CbGpPWpGaD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—urinary bladder cancer	4.85e-05	0.000372	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—urinary bladder cancer	4.84e-05	0.000371	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—urinary bladder cancer	4.82e-05	0.000369	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.81e-05	0.000761	CbGpPWpGaD
Chenodeoxycholic acid—Shock—Epirubicin—urinary bladder cancer	4.79e-05	0.000367	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Doxorubicin—urinary bladder cancer	4.78e-05	0.000367	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—urinary bladder cancer	4.78e-05	0.000366	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.77e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—urinary bladder cancer	4.77e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—urinary bladder cancer	4.75e-05	0.000364	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.74e-05	0.000363	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—urinary bladder cancer	4.73e-05	0.000363	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—urinary bladder cancer	4.71e-05	0.000361	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Methotrexate—urinary bladder cancer	4.71e-05	0.000361	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—urinary bladder cancer	4.7e-05	0.00036	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—urinary bladder cancer	4.7e-05	0.00036	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—urinary bladder cancer	4.7e-05	0.00036	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Methotrexate—urinary bladder cancer	4.67e-05	0.000358	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	4.67e-05	0.000358	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.66e-05	0.000738	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GPX1—urinary bladder cancer	4.65e-05	0.000736	CbGpPWpGaD
Chenodeoxycholic acid—Discomfort—Doxorubicin—urinary bladder cancer	4.64e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—urinary bladder cancer	4.64e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Methotrexate—urinary bladder cancer	4.64e-05	0.000356	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—NQO1—urinary bladder cancer	4.63e-05	0.000733	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Methotrexate—urinary bladder cancer	4.63e-05	0.000355	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—urinary bladder cancer	4.6e-05	0.000352	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Methotrexate—urinary bladder cancer	4.58e-05	0.000351	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ERCC2—urinary bladder cancer	4.57e-05	0.000722	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NCOR1—urinary bladder cancer	4.57e-05	0.000722	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Epirubicin—urinary bladder cancer	4.55e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—urinary bladder cancer	4.54e-05	0.000348	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Methotrexate—urinary bladder cancer	4.52e-05	0.000347	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—urinary bladder cancer	4.51e-05	0.000345	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.49e-05	0.000711	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	4.49e-05	0.000344	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Methotrexate—urinary bladder cancer	4.49e-05	0.000344	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NAT2—urinary bladder cancer	4.48e-05	0.000709	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Doxorubicin—urinary bladder cancer	4.48e-05	0.000343	CcSEcCtD
Chenodeoxycholic acid—Pain—Methotrexate—urinary bladder cancer	4.45e-05	0.000341	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	4.44e-05	0.00034	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—urinary bladder cancer	4.43e-05	0.00034	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—urinary bladder cancer	4.42e-05	0.000339	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.41e-05	0.000338	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—urinary bladder cancer	4.4e-05	0.000338	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—urinary bladder cancer	4.4e-05	0.000337	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—urinary bladder cancer	4.38e-05	0.000335	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—urinary bladder cancer	4.37e-05	0.000335	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—urinary bladder cancer	4.36e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—urinary bladder cancer	4.34e-05	0.000333	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—urinary bladder cancer	4.33e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—urinary bladder cancer	4.3e-05	0.000329	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—MTHFR—urinary bladder cancer	4.29e-05	0.000679	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ERCC2—urinary bladder cancer	4.29e-05	0.000679	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	4.29e-05	0.000329	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—urinary bladder cancer	4.29e-05	0.000329	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	4.26e-05	0.000326	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—urinary bladder cancer	4.23e-05	0.000324	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Doxorubicin—urinary bladder cancer	4.21e-05	0.000323	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	4.2e-05	0.000322	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—urinary bladder cancer	4.2e-05	0.000322	CcSEcCtD
Chenodeoxycholic acid—Constipation—Epirubicin—urinary bladder cancer	4.16e-05	0.000319	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—urinary bladder cancer	4.16e-05	0.000319	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Methotrexate—urinary bladder cancer	4.13e-05	0.000317	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Methotrexate—urinary bladder cancer	4.11e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Methotrexate—urinary bladder cancer	4.11e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4.11e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—urinary bladder cancer	4.08e-05	0.000312	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	4.05e-05	0.00031	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—urinary bladder cancer	4.02e-05	0.000308	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	4.01e-05	0.000308	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—urinary bladder cancer	4.01e-05	0.000307	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.98e-05	0.000305	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—urinary bladder cancer	3.97e-05	0.000304	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.92e-05	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	3.92e-05	0.0003	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.89e-05	0.000298	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—urinary bladder cancer	3.89e-05	0.000298	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—urinary bladder cancer	3.87e-05	0.000613	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Epirubicin—urinary bladder cancer	3.87e-05	0.000296	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—RRM2—urinary bladder cancer	3.87e-05	0.000612	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—urinary bladder cancer	3.86e-05	0.000611	CbGpPWpGaD
Chenodeoxycholic acid—Pain—Doxorubicin—urinary bladder cancer	3.85e-05	0.000295	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—urinary bladder cancer	3.85e-05	0.000295	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—urinary bladder cancer	3.85e-05	0.000295	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—urinary bladder cancer	3.85e-05	0.000295	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Methotrexate—urinary bladder cancer	3.83e-05	0.000294	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.74e-05	0.000591	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Methotrexate—urinary bladder cancer	3.73e-05	0.000286	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.71e-05	0.000285	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.68e-05	0.000282	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Methotrexate—urinary bladder cancer	3.68e-05	0.000282	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—TYMS—urinary bladder cancer	3.59e-05	0.000568	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—urinary bladder cancer	3.59e-05	0.000275	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—urinary bladder cancer	3.59e-05	0.000567	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ENO2—urinary bladder cancer	3.58e-05	0.000566	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HPGDS—urinary bladder cancer	3.58e-05	0.000566	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Doxorubicin—urinary bladder cancer	3.58e-05	0.000274	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—urinary bladder cancer	3.56e-05	0.000273	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	3.56e-05	0.000273	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Methotrexate—urinary bladder cancer	3.56e-05	0.000273	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTM1—urinary bladder cancer	3.55e-05	0.000561	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NCOR1—urinary bladder cancer	3.55e-05	0.000561	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Epirubicin—urinary bladder cancer	3.49e-05	0.000268	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARG—urinary bladder cancer	3.48e-05	0.000551	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—urinary bladder cancer	3.47e-05	0.000549	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Epirubicin—urinary bladder cancer	3.45e-05	0.000264	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Methotrexate—urinary bladder cancer	3.44e-05	0.000264	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GPX1—urinary bladder cancer	3.4e-05	0.000538	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CREBBP—urinary bladder cancer	3.34e-05	0.000529	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ERCC2—urinary bladder cancer	3.34e-05	0.000528	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—urinary bladder cancer	3.33e-05	0.000255	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.32e-05	0.000254	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Methotrexate—urinary bladder cancer	3.31e-05	0.000254	CcSEcCtD
Chenodeoxycholic acid—Rash—Methotrexate—urinary bladder cancer	3.28e-05	0.000251	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Methotrexate—urinary bladder cancer	3.28e-05	0.000251	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARG—urinary bladder cancer	3.27e-05	0.000517	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Methotrexate—urinary bladder cancer	3.26e-05	0.00025	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.23e-05	0.000511	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—urinary bladder cancer	3.23e-05	0.000248	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—urinary bladder cancer	3.22e-05	0.000247	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.19e-05	0.000504	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Doxorubicin—urinary bladder cancer	3.19e-05	0.000244	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—CREBBP—urinary bladder cancer	3.14e-05	0.000497	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—MTHFR—urinary bladder cancer	3.14e-05	0.000496	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Epirubicin—urinary bladder cancer	3.1e-05	0.000237	CcSEcCtD
Chenodeoxycholic acid—Nausea—Methotrexate—urinary bladder cancer	3.09e-05	0.000237	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	3.08e-05	0.000236	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—urinary bladder cancer	3.07e-05	0.000235	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—urinary bladder cancer	3.07e-05	0.000235	CcSEcCtD
Chenodeoxycholic acid—Headache—Epirubicin—urinary bladder cancer	3.05e-05	0.000234	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Doxorubicin—urinary bladder cancer	2.98e-05	0.000228	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.97e-05	0.00047	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.93e-05	0.000464	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Epirubicin—urinary bladder cancer	2.89e-05	0.000222	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NQO1—urinary bladder cancer	2.89e-05	0.000457	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Doxorubicin—urinary bladder cancer	2.87e-05	0.00022	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—urinary bladder cancer	2.84e-05	0.000218	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—urinary bladder cancer	2.84e-05	0.000218	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—urinary bladder cancer	2.82e-05	0.000216	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—urinary bladder cancer	2.74e-05	0.000433	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—urinary bladder cancer	2.68e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARG—urinary bladder cancer	2.54e-05	0.000402	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CREBBP—urinary bladder cancer	2.44e-05	0.000387	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	2.41e-05	0.000381	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—urinary bladder cancer	2.39e-05	0.000378	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EP300—urinary bladder cancer	2.28e-05	0.00036	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TYMS—urinary bladder cancer	2.24e-05	0.000354	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	2.21e-05	0.00035	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	2.21e-05	0.00035	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GPX1—urinary bladder cancer	2.12e-05	0.000335	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	2.08e-05	0.000329	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—urinary bladder cancer	2e-05	0.000317	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.98e-05	0.000313	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000309	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.88e-05	0.000297	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.88e-05	0.000297	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—urinary bladder cancer	1.87e-05	0.000295	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—urinary bladder cancer	1.75e-05	0.000276	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.72e-05	0.000272	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—EP300—urinary bladder cancer	1.66e-05	0.000263	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.000251	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.55e-05	0.000245	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	1.52e-05	0.000241	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.46e-05	0.000231	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.42e-05	0.000225	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	0.000197	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.14e-05	0.00018	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—urinary bladder cancer	1.09e-05	0.000172	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EP300—urinary bladder cancer	1.04e-05	0.000164	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.03e-05	0.000163	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.88e-06	0.00014	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.23e-06	0.00013	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.23e-06	0.00013	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.98e-06	0.000126	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.63e-06	0.000105	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.53e-06	8.75e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.14e-06	8.13e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.08e-06	8.04e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.08e-06	8.04e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.87e-06	7.7e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.78e-06	7.56e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.49e-06	7.1e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.64e-06	5.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.5e-06	5.53e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.86e-06	4.53e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.5e-06	3.95e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.38e-06	3.77e-05	CbGpPWpGaD
